Thursday, January 20, 2022
HomeUncategorizedNIH Research Highlights Increased Post-COVID-19 Risk of Pediatric Diabetes, Pfizer Vaccine’s Effectiveness...

NIH Research Highlights Increased Post-COVID-19 Risk of Pediatric Diabetes, Pfizer Vaccine’s Effectiveness in Preventing MIS-C in Adolescents and Teens

​The National Institutes of Health last week released a pair of studies offering fresh insights into COVID-19’s long-term effect on pediatric groups. The first study evaluates the effectiveness of Pfizer’s COVID-19 vaccine as a mean for preventing multisystem inflammatory syndrome in children, more commonly known as “MIS-C.” Researchers found that the Pfizer vaccine, when used for individuals between the ages of 12 and 18, was 91% effective in preventing MIS-C, which is observed to occur two to six weeks after SARS-CoV-2 infection and can be fatal in some cases. According to the study, among critically ill MIS-C case-patients who required life support, all were unvaccinated.
A second study suggests an increased risk of children developing diabetes following a COVID-19 infection. Researchers after reviewing data from the IQVIA and HealthVerity databases found that patients under the age of 18 were more likely to receive new diabetes diagnoses, beginning 31 days following a COVID-19 infection. The researchers said these findings are consistent with previous research demonstrating an association between SARS-CoV-2 infection and diabetes in adults.

Stay Connected

Unified Voice Newsletter

Events This Month

january

20jan12:00 pm1:00 pmSouth Dakota Inpatient/Outpatient Data SubmissionSDAHO Webinar12:00 pm - 1:00 pm CST Event Type :Education Events,Webinar

25jan12:00 pm1:00 pmEffectively Using the QAPI Process to Implement a Wound ProgramSDAHO Webinar12:00 pm - 1:00 pm CST Event Type :Education Events,Webinar

27jan12:00 pm1:00 pmSD Dimensions: Reports and DashboardsSDAHO Webinar12:00 pm - 1:00 pm CST Event Type :Education Events,Webinar

28jan9:00 am12:00 pmSDSU Nursing Career Fair9:00 am - 12:00 pm CST

X


By submitting this form, you are consenting to receive marketing emails from: SDAHO, 3708 W Brooks Place, Sioux Falls, SD, 57106, http://sdaho.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact